Is Epikast Inc. a real, registered company?
Epikast Inc. is a registered filer with the SEC (CIK 1967033) and has filed since 2023-02-28. 2 filings are on record, the latest on 2026-02-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has Epikast Inc. raised?
Its new offerings report $5.70M sold across 2 offerings, as its own filings state.
Run the free check on Epikast Inc. →
Brooklyn, NEW YORK
2022
Other Health Care
2
$5.70M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2026-02-05 | New offering first sale 2026-01-22 | $700K | $2.20M | details · SEC filing |
| 2023-02-28 | New offering first sale 2023-02-16 | $5M | $10M | SEC filing |
Keep reading
More on Epikast Inc. and the records around it.
Epikast Inc. elsewhere on the record
- Form D filing Feb 2026
Watch Epikast Inc.
Get an email when Epikast Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Epikast Inc.?
Who to contact
- Evangelos Vergetis — Executive Officer, Director
- Stelios Papadopoulos — Director
- Alexandros Tzoukas — Director
- Daphne Karydas — Director
- Oleg Nodelman — Director
- Brad Prosek — Director
- Dimitrios Papalexopoulos — Director
- Round: Form D filed 2026-02-05
- Amount sold: $700K
- Industry: Other Health Care
- Founded: 2022
- Based: Brooklyn, NEW YORK
People listed
- Evangelos Vergetis — Executive Officer, Director
- Stelios Papadopoulos — Director
- Alexandros Tzoukas — Director
- Daphne Karydas — Director
- Oleg Nodelman — Director
- Brad Prosek — Director
- Dimitrios Papalexopoulos — Director
- Filing: Form D filed 2026-02-05
- Amount sold: $700K
- Industry group: Other Health Care
- Year formed: 2022
- Based: Brooklyn, NEW YORK
- Entity type: Corporation
We'll show it in your MentionFox inbox when Epikast Inc. raises, hires or launches. No email unless you switch it on.
Watch Epikast Inc. →Want the whole picture on Epikast Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Epikast Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Epikast Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Epikast Inc.'s own filings with the SEC. The people those filings name are on the team page.
On the SEC's company record
- Epikast Inc. is incorporated in Delaware, according to its company record with the SEC (CIK 1967033).
- The SEC record lists Epikast Inc.'s business address in Brooklyn, NY, as of its latest filing on 2026-02-05.
- Epikast Inc. has 2 filings under its CIK, the first on 2023-02-28: 2 Form D (exempt offering notice) filings (full list).
Read from the company's own record with the SEC on 2026-09-28. Each line links to the record or filing it states.